Medicenna in the spotlight (part VII)

Early biomarker data demonstrates promising T-cell/NK cell activity

This week Medicenna released additional data for their IL-2 program MDNA11. The 3rd cohort (n=4) used a dose of 30 µg/kg (IL-2 content of 6 µg/kg). Remember, MDNA11 is IL-2 (which has weight of 15 kDa) fused with human albumin. Therefore, the IL-2 content is about 20% of the MDNA11 weight (details here). The company plans to dose an additional 3 cohorts…